(Q39245505)

10 September 2017

1 reference

title

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effects (English)

2 references

10 September 2017

https://api.crossref.org/works/10.1016/0002-8703(79)90016-4

3 April 2022

1 reference

Cardiology and cardiovascular medicine

1 reference

Crossref

https://api.crossref.org/works/10.1016/0002-8703(79)90016-4

3 April 2022

author name string

Frishman W

1

1 reference

10 September 2017

Silverman R

2

1 reference

10 September 2017

W. Frishman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A34990

3 April 2022

R. Silverman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A34990

3 April 2022

language of work or name

English

0 references

publication date

1 June 1979

1 reference

full work available at URL

10 September 2017

https://api.elsevier.com/content/article/PII:0002870379900164?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/0002-8703(79)90016-4

https://api.elsevier.com/content/article/PII:0002870379900164?httpAccept=text/plain

3 April 2022

1 reference

Crossref

https://api.crossref.org/works/10.1016/0002-8703(79)90016-4

3 April 2022

published in

American Heart Journal

1 reference

10 September 2017

97

1 reference

10 September 2017

6

1 reference

10 September 2017

797-807

1 reference

Comparative studies on central factors contributing to the hypotensive action of propranolol, alprenolol, and their enantiomers.

10 September 2017

5

8

488

Comparative studies on central factors contributing to the hypotensive action of propranolol, alprenolol and their enantiomers (English)

0 references

Identifiers

1 reference

10 September 2017

1 reference